LXEO icon

Lexeo Therapeutics
LXEO

Overview Fund Activity

31 hedge funds and large institutions have $217M invested in Lexeo Therapeutics in 2023 Q4 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+31
Holders Change %
–
% of All Funds
0.45%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
31
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
EAM
Eventide Asset Management
Massachusetts
$40.3M
2
DCP
D1 Capital Partners
New York
$33.6M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
$31.3M
4
OFM
Omega Fund Management
Massachusetts
$29M
5
Citadel Advisors
Citadel Advisors
Florida
$28M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of America
26
Bank of America
North Carolina
$109K +$109K +8,128 New
TRCT
27
Tower Research Capital (TRC)
New York
$20K +$20K +1,490 New
Qube Research & Technologies (QRT)
28
Qube Research & Technologies (QRT)
United Kingdom
$8.09K +$8.09K +603 New
SPIA
29
Steward Partners Investment Advisory
New York
$4.34K +$4.34K +323 New
JPMorgan Chase & Co
30
JPMorgan Chase & Co
New York
$1.5K +$1.5K +112 New
Wells Fargo
31
Wells Fargo
California
$966 +$966 +72 New
1
2